Business Description
Cardinal Health Inc
NAICS : 424210
SIC : 5122
ISIN : US14149Y1082
Share Class Description:
CAH: Ordinary SharesTotal Employee Number:
57,700Compare
Compare
Traded in other countries / regions
CAH.USA0HTG.UKCAH.MexicoCLH.GermanyCAH.ArgentinaC1AH34.Brazil1CAH.Italy Index Membership
S&P 500Russell 1000Russell 3000MSCI World Index IPO Date
1983-08-04Description
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.55 | |||||
Equity-to-Asset | -0.05 | |||||
Debt-to-Equity | -3.08 | |||||
Debt-to-EBITDA | 2.56 | |||||
Interest Coverage | 9.12 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.07 | |||||
Beneish M-Score | -2.68 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.1 | |||||
3-Year EBITDA Growth Rate | 38.8 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 28.4 | |||||
3-Year Book Growth Rate | -1.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.28 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.77 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.02 | |||||
9-Day RSI | 50.85 | |||||
14-Day RSI | 51.98 | |||||
3-1 Month Momentum % | 16.34 | |||||
6-1 Month Momentum % | 1.43 | |||||
12-1 Month Momentum % | 55.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.88 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 26.82 | |||||
Days Sales Outstanding | 19.56 | |||||
Days Payable | 55.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.87 | |||||
Dividend Payout Ratio | 0.19 | |||||
3-Year Dividend Growth Rate | 1 | |||||
Forward Dividend Yield % | 0.88 | |||||
5-Year Yield-on-Cost % | 0.92 | |||||
3-Year Average Share Buyback Ratio | 2.4 | |||||
Shareholder Yield % | 0.21 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 3.84 | |||||
Operating Margin % | 1.25 | |||||
Net Margin % | 0.67 | |||||
EBITDA Margin % | 1.37 | |||||
FCF Margin % | 1.78 | |||||
OCF Margin % | 2.04 | |||||
ROE % | Neg. Equity | |||||
ROA % | 3.06 | |||||
ROIC % | 13.34 | |||||
3-Year ROIIC % | 15.98 | |||||
ROC (Joel Greenblatt) % | 86.82 | |||||
ROCE % | 17.5 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 32.4 | |||||
Forward PE Ratio | 18.68 | |||||
PE Ratio without NRI | 21.42 | |||||
Shiller PE Ratio | 167.44 | |||||
Price-to-Owner-Earnings | 14.04 | |||||
PEG Ratio | 0.3 | |||||
PS Ratio | 0.22 | |||||
Price-to-Free-Cash-Flow | 12.24 | |||||
Price-to-Operating-Cash-Flow | 10.7 | |||||
EV-to-EBIT | 23.29 | |||||
EV-to-Forward-EBIT | 19.46 | |||||
EV-to-EBITDA | 16.89 | |||||
EV-to-Forward-EBITDA | 14.68 | |||||
EV-to-Revenue | 0.23 | |||||
EV-to-Forward-Revenue | 0.22 | |||||
EV-to-FCF | 12.98 | |||||
Price-to-GF-Value | 1.55 | |||||
Price-to-Projected-FCF | 1.74 | |||||
Price-to-Median-PS-Value | 1.84 | |||||
Earnings Yield (Greenblatt) % | 4.29 | |||||
FCF Yield % | 8.3 | |||||
Forward Rate of Return (Yacktman) % | -0.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CAH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cardinal Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 254,248 | ||
| EPS (TTM) ($) | 7.24 | ||
| Beta | 0.3474 | ||
| 3-Year Sharpe Ratio | 1.11 | ||
| 3-Year Sortino Ratio | 2.53 | ||
| Volatility % | 35.06 | ||
| 14-Day RSI | 51.98 | ||
| 14-Day ATR ($) | 5.551196 | ||
| 20-Day SMA ($) | 235.114 | ||
| 12-1 Month Momentum % | 55.51 | ||
| 52-Week Range ($) | 145.87 - 258.3021 | ||
| Shares Outstanding (Mil) | 232.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cardinal Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cardinal Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2027-02-05 08:30 | In 161 days | ||
| Second quarter earnings results for 2027 | 2027-02-05 | In 160 days | ||
| General meeting for 2026 | 2026-11-05 08:00 | In 69 days | ||
| First quarter earnings conference call for 2027 | 2026-10-30 08:30 | In 63 days | ||
| First quarter earnings results for 2027 | 2026-10-30 | In 62 days | ||
| USD 0.515800 Cash Dividend | 2026-10-01 | In 33 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-11 08:30 | 237.18 (+0.36%) | ||
| Annual report for 2026 | 2026-08-11 | 237.18 (+0.36%) | ||
| Fourth quarter earnings results for 2026 | 2026-08-11 | 237.18 (+0.36%) | ||
| USD 0.515800 Cash Dividend | 2026-07-01 | 237.56 (+0.24%) |
Show
Entries
Cardinal Health Inc Frequently Asked Questions
What is Cardinal Health Inc(CAH)'s stock price today?
The current price of CAH is $234.55. The 52 week high of CAH is $258.30 and 52 week low is $145.87.
When is next earnings date of Cardinal Health Inc(CAH)?
The next earnings date of Cardinal Health Inc(CAH) is 2026-10-30 Est..
Does Cardinal Health Inc(CAH) pay dividends? If so, how much?
The Dividend Yield %  of Cardinal Health Inc(CAH) is 0.87% (As of Today), Highest Dividend Payout Ratio of Cardinal Health Inc(CAH) was 0.47. The lowest was 0.19. And the median was 0.35. The  Forward Dividend Yield % of Cardinal Health Inc(CAH) is 0.88%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:CAH
2025 Q3
What the manager wrote
We built a meaningful position in Cardinal Health (CAH), one of the three major U.S. drug distributors, which continues to benefit from rising demand for complex specialty and biologic therapies. The company is expanding its value-added service offerings and serves adjacent markets such as third-party logistics and the fast-growing nuclear medicine space. Its medical distribution business remains an execution turnaround story, with new management narrowing service gaps with peers and showing early progress in improving margins.
Press Release
Articles on Cardinal Health Inc
Headlines
See More- 1
Aug 19, 2026
Cardinal Health a new outperform at RBC on higher margin services
Seeking Alpha • 9:34am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers